Author

Robert L. Furler O’Brien

Weill Cornell MedicineORCID 0000-0001-5706-4871Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:imaging· 2 Approach:microscopy & imaging analysis· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Colin M KovacsiD· 1 shared Daniel Dunn· 1 shared Douglas F. NixoniD· 1 shared Jacqueline M. CrateriD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Colin M KovacsORCID

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 27, 2023

A Subset of HIV 1 Controllers Lack Cortical Actin Disruption Indicative of ARP2/3 Inhibition.

Robert L. Furler O’Brien, Colin M Kovacs

The paper identifies that some HIV-1 controllers lack actin disruption typical of ARP2/3 inhibition, suggesting a protective mechanism against immune dysfunction.

DOI 10.1101/2023.07.27.550860

humanimaging

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 27, 2023

HIV-1 Mediated Cortical Actin Disruption Mirrors ARP2/3 Defects Found in Primary T Cell Immunodeficiencies.

Jacqueline M. Crater, Daniel Dunn, Douglas F. Nixon, Robert L. Furler O’Brien

This study shows HIV-1 infection disrupts cortical actin in CD4+ T cells, mimicking ARP2/3 defects in immunodeficiencies, and identifies ARP2/3 as a potential therapeutic target.

DOI 10.1101/2023.07.27.550856

humanimaging

𝕏 PostBluesky